AU Stock MarketDetailed Quotes

PARO Paradigm Biopharmaceuticals Ltd

Watchlist

0.023
0.0000.00%

20min DelayTrading Jul 19 15:30 AET

8.06MMarket Cap0.00P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

-40.98%46.76K

285.52%79.22K

20.55K

Operating revenue

-40.98%46.76K

285.52%79.22K

--20.55K

----

Cost of revenue

-86.90%18.83K

45.00%143.75K

99.14K

Gross profit

143.29%27.93K

17.89%-64.53K

-78.59K

Operating expense

25.33%60.07M

10.65%47.93M

152.21%43.31M

67.98%17.17M

10.22M

Selling and administrative expenses

-17.26%6.56M

-9.30%7.93M

109.96%8.75M

79.71%4.17M

--2.32M

-General and administrative expense

-17.26%6.56M

-9.30%7.93M

109.96%8.75M

79.71%4.17M

--2.32M

Research and development costs

35.03%52.68M

16.39%39.01M

161.98%33.52M

62.01%12.79M

--7.9M

Depreciation amortization depletion

----

-70.98%60.97K

-1.44%210.06K

2,452.92%213.12K

--8.35K

-Depreciation and amortization

----

-70.98%60.97K

-1.44%210.06K

2,452.92%213.12K

--8.35K

Other operating expenses

-10.47%822.7K

9.80%918.86K

--836.88K

----

Operating profit

-25.10%-60.04M

-10.60%-47.99M

-152.66%-43.39M

-67.98%-17.17M

-10.22M

Net non-operating interest income (expenses)

5,897.84%1.39M

-86.52%23.11K

-82.21%171.4K

268.15%963.48K

261.71K

Non-operating interest income

2,610.61%1.4M

-75.26%51.74K

-79.04%209.13K

281.20%997.65K

--261.71K

Non-operating interest expense

-42.67%16.42K

-24.09%28.63K

10.40%37.72K

--34.17K

----

Other net income (expenses)

-22.12%6.74M

-0.63%8.66M

135.60%8.71M

165.17%3.7M

-5.67M

Special income (charges)

----

---6.93M

-Less:Impairment of capital assets

----

--6.93M

Other non-operating income (expenses)

-22.12%6.74M

-0.63%8.66M

135.60%8.71M

194.66%3.7M

--1.25M

Income before tax

-32.26%-51.91M

-14.44%-39.25M

-178.86%-34.3M

21.30%-12.3M

-15.63M

Income tax

Earnings from equity interest net of tax

Net income

-32.26%-51.91M

-14.44%-39.25M

-178.86%-34.3M

21.30%-12.3M

-15.63M

Net income continuous operations

-32.26%-51.91M

-14.44%-39.25M

-178.86%-34.3M

21.30%-12.3M

---15.63M

Noncontrolling interests

Net income attributable to the company

-32.26%-51.91M

-14.44%-39.25M

-178.86%-34.3M

21.30%-12.3M

-15.63M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-32.26%-51.91M

-14.44%-39.25M

-178.86%-34.3M

21.30%-12.3M

-15.63M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue	-40.98%46.76K	285.52%79.22K	20.55K
Operating revenue	-40.98%46.76K	285.52%79.22K	--20.55K	----	----
Cost of revenue	-86.90%18.83K	45.00%143.75K	99.14K
Gross profit	143.29%27.93K	17.89%-64.53K	-78.59K
Operating expense	25.33%60.07M	10.65%47.93M	152.21%43.31M	67.98%17.17M	10.22M
Selling and administrative expenses	-17.26%6.56M	-9.30%7.93M	109.96%8.75M	79.71%4.17M	--2.32M
-General and administrative expense	-17.26%6.56M	-9.30%7.93M	109.96%8.75M	79.71%4.17M	--2.32M
Research and development costs	35.03%52.68M	16.39%39.01M	161.98%33.52M	62.01%12.79M	--7.9M
Depreciation amortization depletion	----	-70.98%60.97K	-1.44%210.06K	2,452.92%213.12K	--8.35K
-Depreciation and amortization	----	-70.98%60.97K	-1.44%210.06K	2,452.92%213.12K	--8.35K
Other operating expenses	-10.47%822.7K	9.80%918.86K	--836.88K	----	----
Operating profit	-25.10%-60.04M	-10.60%-47.99M	-152.66%-43.39M	-67.98%-17.17M	-10.22M
Net non-operating interest income (expenses)	5,897.84%1.39M	-86.52%23.11K	-82.21%171.4K	268.15%963.48K	261.71K
Non-operating interest income	2,610.61%1.4M	-75.26%51.74K	-79.04%209.13K	281.20%997.65K	--261.71K
Non-operating interest expense	-42.67%16.42K	-24.09%28.63K	10.40%37.72K	--34.17K	----
Other net income (expenses)	-22.12%6.74M	-0.63%8.66M	135.60%8.71M	165.17%3.7M	-5.67M
Special income (charges)	----	----	----	----	---6.93M
-Less:Impairment of capital assets	----	----	----	----	--6.93M
Other non-operating income (expenses)	-22.12%6.74M	-0.63%8.66M	135.60%8.71M	194.66%3.7M	--1.25M
Income before tax	-32.26%-51.91M	-14.44%-39.25M	-178.86%-34.3M	21.30%-12.3M	-15.63M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-32.26%-51.91M	-14.44%-39.25M	-178.86%-34.3M	21.30%-12.3M	-15.63M
Net income continuous operations	-32.26%-51.91M	-14.44%-39.25M	-178.86%-34.3M	21.30%-12.3M	---15.63M
Noncontrolling interests
Net income attributable to the company	-32.26%-51.91M	-14.44%-39.25M	-178.86%-34.3M	21.30%-12.3M	-15.63M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-32.26%-51.91M	-14.44%-39.25M	-178.86%-34.3M	21.30%-12.3M	-15.63M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall